FR2267102A1 - 2,6-Di(branched alkylamino)pyridines - for treatment of fatty degeneration and diabetes - Google Patents

2,6-Di(branched alkylamino)pyridines - for treatment of fatty degeneration and diabetes

Info

Publication number
FR2267102A1
FR2267102A1 FR7511211A FR7511211A FR2267102A1 FR 2267102 A1 FR2267102 A1 FR 2267102A1 FR 7511211 A FR7511211 A FR 7511211A FR 7511211 A FR7511211 A FR 7511211A FR 2267102 A1 FR2267102 A1 FR 2267102A1
Authority
FR
France
Prior art keywords
alkyl
treatment
pyridines
diabetes
fatty degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7511211A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2267102A1 publication Critical patent/FR2267102A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7511211A 1974-04-12 1975-04-10 2,6-Di(branched alkylamino)pyridines - for treatment of fatty degeneration and diabetes Withdrawn FR2267102A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46028674A 1974-04-12 1974-04-12
US53394174A 1974-12-18 1974-12-18

Publications (1)

Publication Number Publication Date
FR2267102A1 true FR2267102A1 (en) 1975-11-07

Family

ID=27039622

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7511211A Withdrawn FR2267102A1 (en) 1974-04-12 1975-04-10 2,6-Di(branched alkylamino)pyridines - for treatment of fatty degeneration and diabetes

Country Status (11)

Country Link
JP (1) JPS50140456A (tr)
AU (1) AU8003675A (tr)
DD (1) DD119230A5 (tr)
DE (1) DE2514558A1 (tr)
DK (1) DK142675A (tr)
FI (1) FI750998A (tr)
FR (1) FR2267102A1 (tr)
IL (1) IL47066A0 (tr)
NL (1) NL7504157A (tr)
NO (1) NO751158L (tr)
SE (1) SE7503889L (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2118075B1 (tr) * 1970-12-19 1976-04-30 Basf Ag
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
DE3637829A1 (de) * 1986-11-06 1988-05-11 Asta Pharma Ag Neue 2,6-diamino-3-halogenobenzylpyridine und verfahren zu ihrer herstellung sowie ihre verwendung in pharmazeutika

Also Published As

Publication number Publication date
NL7504157A (nl) 1975-10-14
JPS50140456A (tr) 1975-11-11
IL47066A0 (en) 1975-06-25
DE2514558A1 (de) 1975-10-23
DK142675A (tr) 1975-10-13
AU8003675A (en) 1976-10-14
SE7503889L (sv) 1975-10-13
FI750998A (tr) 1975-10-13
DD119230A5 (tr) 1976-04-12
NO751158L (tr) 1975-10-14

Similar Documents

Publication Publication Date Title
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
ZA895613B (en) Chemical compounds
DE68917485T2 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
ES8104230A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,fenil-3-(4-piperidil)-1-propanona.
DK0615754T3 (da) Faste flupertinholdige orale administrationsformer med kontrolleret frigivelse af den aktive forbindelse
ATE156119T1 (de) 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel
RO117150B1 (ro) Metodă pentru tratamentul afecţiunilor provocate de abuzul faţă de drog sau altă substanţă
FR2267102A1 (en) 2,6-Di(branched alkylamino)pyridines - for treatment of fatty degeneration and diabetes
GB1187299A (en) Improvements in or relating to Heterocyclic Compounds and the manufacture thereof
ES431497A1 (es) Procedimiento para preparar un derivado de s-triazol (1,5- a) piridina.
ES2075429T3 (es) Derivados de 4,5-cicloalcano-3-benzazepin-7-ol y sus usos.
NO162907C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bis-(piperazinyl-resp. homopiperazinyl)-alkaner.
ES2083983T3 (es) Sales del acido n5-n10-metilen-5,6,7,8-tetrahidrofolico.
LU90791I2 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
IE38361L (en) Fish feed
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
HUP0104533A2 (hu) Új pirimidinszármazékok és eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények
GR78622B (tr)
SE8004351L (sv) (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyra-anilider och fysiologiskt fordragbara syraadditionssalter derav samt lekemedel med en halt av dessa foreningar
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
YU119491A (sh) Novi protivirusni tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja
ES544268A0 (es) Un procedimiento para preparar derivados de tioimidazol
ATE1599T1 (de) 1,2,4-triazolylenolether enthaltende pharmazeutische zusammensetzungen und deren herstellung.
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat

Legal Events

Date Code Title Description
ST Notification of lapse